Second Malignancy Masquerading as Recurrence of Neuroendocrine Tumor

Neuroendocrine tumors (NETs) may mimic many endocrine syndromes, including Cushing syndrome (CS) secondary to ectopic ACTH secretion. Radiotherapy (RT) is often used as adjuvant therapy for such persistent or recurrent NETs. However, RT may predispose a susceptible person to a second malignancy. Her...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JCEM case reports 2024, Vol.2 (2), p.luad127-luad127
Hauptverfasser: Chakraborty, Ananda Mohan, Bhardwaj, Neha, Rastogi, Ashu, Bhadada, Sanjay Kumar
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page luad127
container_issue 2
container_start_page luad127
container_title JCEM case reports
container_volume 2
creator Chakraborty, Ananda Mohan
Bhardwaj, Neha
Rastogi, Ashu
Bhadada, Sanjay Kumar
description Neuroendocrine tumors (NETs) may mimic many endocrine syndromes, including Cushing syndrome (CS) secondary to ectopic ACTH secretion. Radiotherapy (RT) is often used as adjuvant therapy for such persistent or recurrent NETs. However, RT may predispose a susceptible person to a second malignancy. Here, we reported the story of a 37-year-old male, who presented with progressive weight loss, bone pain, and shortness of breath in the emergency department. He was diagnosed with CS secondary to a carcinoid tumor in the bronchopulmonary tree a decade previous and underwent total bilateral adrenalectomy. He also underwent lobectomy, and subsequent RT for a primary NET and was in clinical remission. His presenting symptoms were considered a recurrence of pulmonary NETs. However, the biopsy suggested high-grade mucoepidermoid carcinoma (MEC). MEC of the lung is a rare tumor with a prevalence of
doi_str_mv 10.1210/jcemcr/luad127
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2919744182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2919744182</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_29197441823</originalsourceid><addsrcrecordid>eNqVjL0OwiAYAImJiY12dWZ0qQVsg8z-xEUH7d4Q-NrQUFCQwbe3gy_gdDdcDqE1JVvKKCkHBaMKpU1SU8ZnKGO8rgtaM7JAeYwDIYQJQQRnGTo-QHmn8VVa0zvp1GfS-EoQpDauxzLiO6gUAjgF2Hf4Bil4cNqrYBzgJo0-rNC8kzZC_uMSbc6n5nApnsFPq_huRxMVWCsd-BRbJqjgVUX3bPdH-gVGI0Vw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2919744182</pqid></control><display><type>report</type><title>Second Malignancy Masquerading as Recurrence of Neuroendocrine Tumor</title><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Chakraborty, Ananda Mohan ; Bhardwaj, Neha ; Rastogi, Ashu ; Bhadada, Sanjay Kumar</creator><creatorcontrib>Chakraborty, Ananda Mohan ; Bhardwaj, Neha ; Rastogi, Ashu ; Bhadada, Sanjay Kumar</creatorcontrib><description>Neuroendocrine tumors (NETs) may mimic many endocrine syndromes, including Cushing syndrome (CS) secondary to ectopic ACTH secretion. Radiotherapy (RT) is often used as adjuvant therapy for such persistent or recurrent NETs. However, RT may predispose a susceptible person to a second malignancy. Here, we reported the story of a 37-year-old male, who presented with progressive weight loss, bone pain, and shortness of breath in the emergency department. He was diagnosed with CS secondary to a carcinoid tumor in the bronchopulmonary tree a decade previous and underwent total bilateral adrenalectomy. He also underwent lobectomy, and subsequent RT for a primary NET and was in clinical remission. His presenting symptoms were considered a recurrence of pulmonary NETs. However, the biopsy suggested high-grade mucoepidermoid carcinoma (MEC). MEC of the lung is a rare tumor with a prevalence of &lt;1% of all lung malignancies. MEC of the lung after RT for bronchial NET-causing ectopic CS has not yet been reported in the literature. The present patient did not survive despite achieving remission of CS and primary tumor because of the aggressive second malignancy attributed to RT, which was given for the primary tumor.</description><identifier>EISSN: 2755-1520</identifier><identifier>DOI: 10.1210/jcemcr/luad127</identifier><language>eng</language><ispartof>JCEM case reports, 2024, Vol.2 (2), p.luad127-luad127</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>778,782,4478,27908</link.rule.ids></links><search><creatorcontrib>Chakraborty, Ananda Mohan</creatorcontrib><creatorcontrib>Bhardwaj, Neha</creatorcontrib><creatorcontrib>Rastogi, Ashu</creatorcontrib><creatorcontrib>Bhadada, Sanjay Kumar</creatorcontrib><title>Second Malignancy Masquerading as Recurrence of Neuroendocrine Tumor</title><title>JCEM case reports</title><description>Neuroendocrine tumors (NETs) may mimic many endocrine syndromes, including Cushing syndrome (CS) secondary to ectopic ACTH secretion. Radiotherapy (RT) is often used as adjuvant therapy for such persistent or recurrent NETs. However, RT may predispose a susceptible person to a second malignancy. Here, we reported the story of a 37-year-old male, who presented with progressive weight loss, bone pain, and shortness of breath in the emergency department. He was diagnosed with CS secondary to a carcinoid tumor in the bronchopulmonary tree a decade previous and underwent total bilateral adrenalectomy. He also underwent lobectomy, and subsequent RT for a primary NET and was in clinical remission. His presenting symptoms were considered a recurrence of pulmonary NETs. However, the biopsy suggested high-grade mucoepidermoid carcinoma (MEC). MEC of the lung is a rare tumor with a prevalence of &lt;1% of all lung malignancies. MEC of the lung after RT for bronchial NET-causing ectopic CS has not yet been reported in the literature. The present patient did not survive despite achieving remission of CS and primary tumor because of the aggressive second malignancy attributed to RT, which was given for the primary tumor.</description><issn>2755-1520</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2024</creationdate><recordtype>report</recordtype><recordid>eNqVjL0OwiAYAImJiY12dWZ0qQVsg8z-xEUH7d4Q-NrQUFCQwbe3gy_gdDdcDqE1JVvKKCkHBaMKpU1SU8ZnKGO8rgtaM7JAeYwDIYQJQQRnGTo-QHmn8VVa0zvp1GfS-EoQpDauxzLiO6gUAjgF2Hf4Bil4cNqrYBzgJo0-rNC8kzZC_uMSbc6n5nApnsFPq_huRxMVWCsd-BRbJqjgVUX3bPdH-gVGI0Vw</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Chakraborty, Ananda Mohan</creator><creator>Bhardwaj, Neha</creator><creator>Rastogi, Ashu</creator><creator>Bhadada, Sanjay Kumar</creator><scope>7X8</scope></search><sort><creationdate>20240201</creationdate><title>Second Malignancy Masquerading as Recurrence of Neuroendocrine Tumor</title><author>Chakraborty, Ananda Mohan ; Bhardwaj, Neha ; Rastogi, Ashu ; Bhadada, Sanjay Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_29197441823</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Chakraborty, Ananda Mohan</creatorcontrib><creatorcontrib>Bhardwaj, Neha</creatorcontrib><creatorcontrib>Rastogi, Ashu</creatorcontrib><creatorcontrib>Bhadada, Sanjay Kumar</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chakraborty, Ananda Mohan</au><au>Bhardwaj, Neha</au><au>Rastogi, Ashu</au><au>Bhadada, Sanjay Kumar</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Second Malignancy Masquerading as Recurrence of Neuroendocrine Tumor</atitle><jtitle>JCEM case reports</jtitle><date>2024-02-01</date><risdate>2024</risdate><volume>2</volume><issue>2</issue><spage>luad127</spage><epage>luad127</epage><pages>luad127-luad127</pages><eissn>2755-1520</eissn><abstract>Neuroendocrine tumors (NETs) may mimic many endocrine syndromes, including Cushing syndrome (CS) secondary to ectopic ACTH secretion. Radiotherapy (RT) is often used as adjuvant therapy for such persistent or recurrent NETs. However, RT may predispose a susceptible person to a second malignancy. Here, we reported the story of a 37-year-old male, who presented with progressive weight loss, bone pain, and shortness of breath in the emergency department. He was diagnosed with CS secondary to a carcinoid tumor in the bronchopulmonary tree a decade previous and underwent total bilateral adrenalectomy. He also underwent lobectomy, and subsequent RT for a primary NET and was in clinical remission. His presenting symptoms were considered a recurrence of pulmonary NETs. However, the biopsy suggested high-grade mucoepidermoid carcinoma (MEC). MEC of the lung is a rare tumor with a prevalence of &lt;1% of all lung malignancies. MEC of the lung after RT for bronchial NET-causing ectopic CS has not yet been reported in the literature. The present patient did not survive despite achieving remission of CS and primary tumor because of the aggressive second malignancy attributed to RT, which was given for the primary tumor.</abstract><doi>10.1210/jcemcr/luad127</doi></addata></record>
fulltext fulltext
identifier EISSN: 2755-1520
ispartof JCEM case reports, 2024, Vol.2 (2), p.luad127-luad127
issn 2755-1520
language eng
recordid cdi_proquest_miscellaneous_2919744182
source Oxford Journals Open Access Collection; PubMed Central
title Second Malignancy Masquerading as Recurrence of Neuroendocrine Tumor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A15%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Second%20Malignancy%20Masquerading%20as%20Recurrence%20of%20Neuroendocrine%20Tumor&rft.jtitle=JCEM%20case%20reports&rft.au=Chakraborty,%20Ananda%20Mohan&rft.date=2024-02-01&rft.volume=2&rft.issue=2&rft.spage=luad127&rft.epage=luad127&rft.pages=luad127-luad127&rft.eissn=2755-1520&rft_id=info:doi/10.1210/jcemcr/luad127&rft_dat=%3Cproquest%3E2919744182%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2919744182&rft_id=info:pmid/&rfr_iscdi=true